|
|
||||||||
1 Wihuri Research Institute, FIN-00140 Helsinki; 2 Institute of Biotechnology, University of Helsinki Biocentrum, FIN-00710 Helsinki; and 3 Division of Cardiology, Helsinki University Hospital, FIN-00290 Helsinki, Finland
Because bradykinin (BK) appears to have cardioprotective effects ranging from improved hemodynamics to antiproliferative effects, inhibition of BK-degrading enzymes should potentiate such actions. The purpose of this study was to find out which enzymes are responsible for the degradation of BK in human plasma. Human plasma from healthy donors (n = 10) was incubated with BK in the presence or absence of specific enzyme inhibitors. At high (micromolar) concentrations, BK was mostly (>90%) degraded by carboxypeptidase N (CPN)-like activity. In contrast, at low (nanomolar) substrate concentrations, at which the velocity of the catalytic reaction is equivalent to that under physiological conditions, BK was mostly (>90%) converted into an inactive metabolite, BK-(1-7), by angiotensin-converting enzyme (ACE). BK-(1-7) was further converted by ACE into BK-(1-5), with accumulation of this active peptide. A minor fraction (<10%) of the BK was converted into another active metabolite, BK-(1-8), by CPN-like activity. The present study shows that the most critical step in plasma kinin metabolism, i.e., inactivation of BK, is mediated by ACE. Thus inhibition of plasma ACE activity would be cardioprotective by elevating the concentration of BK in the circulation.
kininase I; kininase II; peptides
This article has been cited by other articles:
![]() |
E. B. Oliveira, L. L. Souza, D. O. Sivieri Jr, L. B. Bispo-da-Silva, H. J. V. Pereira, C. M. Costa-Neto, M. V. Sousa, and M. C. O. Salgado Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3550 - H3557. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dendorfer, S. Wolfrum, M. Wagemann, F. Qadri, and P. Dominiak Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2182 - H2188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |